MedTrace Logo

Bern Venous Stent Registry

NCT02433054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 548

Last updated 2023-10-12

No results posted yet for this study

Summary

The purpose of this study is to examine patency rates of self-expanding nitinol stents for treatment of iliofemoral and inferior vena cava residual thrombosis, obstruction or stenosis. Moreover, clinical outcome data of patients treated with these venous stents will be collected.

Conditions

  • Post-thrombotic Syndrome

Interventions

DEVICE

CE-certified dedicated venous stents

Implantation of self-expanding nitinol venous stents in the iliofemoral veins and/or inferior vena cava.

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Nils Kucher, Prof. Dr. med. · University Hospital Zurich, Clinic of Angiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2023-04-11
Completion
2023-10-11

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02433054 on ClinicalTrials.gov